Zinacef

Active Ingredient(s): Cefuroxime
FDA Approved: * October 19, 1983
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zinacef Overview

Cefuroxime is an enteral second-generation cephalosporin antibiotic. It was discovered by Glaxo, now GlaxoSmithKline, and first marketed in 1978 as Zinacef. It received approval from the U.S. Food and Drug Administration in October 1983.[1] Cefuroxime axetil is an acetoxyethyl ester prodrug of cefuroxime which is effective orally.[2] Contents 1 Medical uses 2 Side effects 3 Trade names 4 References Medical uses As with the other cephalosporins, it is s...

Read more Zinacef Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefuroxime

Recent Zinacef Forums: RSS Feed

technologist

we practised to use zinacef for UTI organism and its doing well so its drug of chice for UTI ## Thank you for the information. Zinacef contains the active ingredient Cefuroxime, a Cephalosporin class antibiotic, that is used to treat various types of infections. Common side effects may include: nausea, drowsiness, skin rash and diarrhea. Learn more: Are there any questions or comments?

Updated

Possible Dosages for this and Related Drugs:

Cefuroxime
  • For Suspension: 125mg/5ml, 250mg/5ml
  • Injection: 1.5g, 1.5g/100ml, 1.5g/20ml, 1.5g/50ml, 1.5gm/vial, 7.5g, 7.5gm/vial, 750mg, 750mg/50ml, 750mg/vial
  • Powder for Reconstitution: 125mg/5ml, 250mg/5ml
  • Tablet: 125mg, 250mg, 300mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zinacef: (10 results)

Sorted by National Drug Code
  • 0173-0354 Zinacef 1.5 g/16ml Intravenous Injection, Powder, for Solution by Glaxosmithkline LLC
  • 0173-0425 Zinacef 1.5 g/50ml Intravenous Injection, Solution by Glaxosmithkline LLC
  • 0173-0436 Zinacef 750 mg/8.3ml Intravenous Injection, Powder, for Solution by Glaxosmithkline LLC
  • 0173-0437 Zinacef 1.5 g/16ml Intravenous Injection, Powder, for Solution by Glaxosmithkline LLC
  • 24987-352 Zinacef 90 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution by Covis Pharmaceuticals Inc
  • 24987-354 Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution by Covis Pharmaceuticals Inc
  • 24987-400 Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution by Covis Pharmaceuticals Inc
  • 24987-425 Zinacef 1.5 g/50ml Intravenous Injection, Solution by Covis Pharmaceuticals Inc
  • 24987-436 Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution by Covis Pharmaceuticals Inc
  • 24987-437 Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution by Covis Pharmaceuticals Inc

Other drugs which contain Cefuroxime or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA